GloPID-R Scientific Advisory Group

We are delighted to share the findings of GloPID-R Scientific Advisory Group on COVID-19 research priorities for the next 12 to 18 months, along with our Co-Chairs’ recommendations based on the report.

In February 2021, in the face of the uncertainty of a second year of the COVID-19 pandemic, the GloPID-R leadership formed a Scientific Advisory Group whose purpose was to provide recommendations to inform GloPID-R’s coordinated approach to funding research on COVID-19 through early 2023.

The SAG members carried out their work under the guidance of experts from the Oxford Saïd Business School, using a highly innovative method based on scenario planning.

Together they developed and explored three plausible scenarios of what may unfold in the context of a continuing COVID-19 pandemic and its aftermath.

SAG Committee Members

  • Chair: Marion Koopmans (GloPID-R Scientific Advisor)
  • Lina Moses (GOARN Research – Tulane University)
  • Moses Alobo (African Academy of Sciences)
  • Nahoko Shindo (WHO)
  • Nicole Lurie (CEPI)
  • Steven Hoffman (CIHR)
  • Xavier de Lamballerie (University of Marseilles)
  • Yazdan Yazdanpanah (INSERM/ANRS – GloPID-R Vice-Chair)

Download the report
Download the Co-Chair recommendations